Drug Trial Radar · NCT00601107
A Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis
Last checked: Nov 19, 2026Latest source record: May 5, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
111
Actual
Start
Apr 2008
Primary completion
Feb 2009
Study completion Jun 2009
Sponsor
- Lead sponsor
- Genzyme, a Sanofi CompanySanofi (SNY)
- Sponsor type
- Industry
- First posted
- Jan 25, 2008
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study was to evaluate the safety and effectiveness of an investigational drug called doxercalciferol in participants with moderate to severe chronic plaque psoriasis, in comparison with a placebo ("sugar pill"). All study related care was provided including doctor visits, physical exams, laboratory tests and study medication. Total length of participation was 28 weeks.
Conditions
- Moderate to Severe Chronic Plaque Psoriasis
Interventions
DoxercalciferolDrug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With at Least 50 Percent (%) Reduction in Psoriasis Area Severity Index (PASI) Score at Week 12 or Early TerminationTime frame: Week 12 or Early Termination
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Birmingham, Alabama
Site not named
Hot Springs, Arizona
Site not named
Little Rock, Arkansas
Site not named
Irvine, California
Site not named
Santa Monica, California
Site not named
Alpharetta, Georgia
Site not named
Indianapolis, Indiana
Site not named
Andover, Massachusetts
Site not named
Boston, Massachusetts
Site not named
Troy, Michigan
Site not named
West Bloomfield, Michigan
Site not named
St Louis, Missouri
Site not named
East Windsor, New Jersey
Site not named
Albuquerque, New Mexico
Site not named
Stony Brook, New York
Site not named
Greer, South Carolina
Site not named
Nashville, Tennessee
Site not named
San Antonio, Texas
Site not named
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.